GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Carl Zeiss Meditec AG (LTS:0DHC) » Definitions » Other Operating Expense

Carl Zeiss Meditec AG (LTS:0DHC) Other Operating Expense : €-14 Mil (TTM As of Mar. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Carl Zeiss Meditec AG Other Operating Expense?

Carl Zeiss Meditec AG's Other Operating Expense for the three months ended in Mar. 2024 was €-18 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was €-14 Mil.

Carl Zeiss Meditec AG's quarterly Other Operating Expense declined from Sep. 2023 (€4 Mil) to Dec. 2023 (€0 Mil) and declined from Dec. 2023 (€0 Mil) to Mar. 2024 (€-18 Mil).

Carl Zeiss Meditec AG's annual Other Operating Expense increased from Sep. 2021 (€-2 Mil) to Sep. 2022 (€1 Mil) and increased from Sep. 2022 (€1 Mil) to Sep. 2023 (€4 Mil).


Carl Zeiss Meditec AG Other Operating Expense Historical Data

The historical data trend for Carl Zeiss Meditec AG's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Carl Zeiss Meditec AG Other Operating Expense Chart

Carl Zeiss Meditec AG Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -2.45 1.29 4.31

Carl Zeiss Meditec AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 4.31 - -18.18

Carl Zeiss Meditec AG Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-14 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Carl Zeiss Meditec AG Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Carl Zeiss Meditec AG's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Carl Zeiss Meditec AG (LTS:0DHC) Business Description

Address
Goschwitzer Strasse 51-52, Jena, TH, DEU, 07745
Carl Zeiss Meditec is one of the largest medical technology companies in the world and it operates in two segments: Ophthalmic devices and Microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.

Carl Zeiss Meditec AG (LTS:0DHC) Headlines

No Headlines